M. Suzuki et al., MACROPHAGE-COLONY-STIMULATING FACTOR AS A MARKER FOR MALIGNANT GERM-CELL TUMORS OF THE OVARY, Gynecologic oncology, 68(1), 1998, pp. 35-37
We assessed the usefulness of macrophage colony-stimulating factor (M-
CSF) as a serum marker for malignant germ cell tumors of the ovary. Se
rum levels of M-CSF were measured in 49 patients with malignant germ c
ell tumors and in 64 patients with mature benign cystic teratoma by an
enzyme-linked immunosorbent assay. CA125 was measured by radioimmunoa
ssay. The serum level of M-CSF was above normal (>1056 U/ml) in 44 (90
%) of 49 patients with malignant germ cell tumors; the CA125 level was
above the cutoff value (35 U/ml) in 34 patients (69%) (P < 0.05). The
serum level of M-CSF was elevated in 20 (87%) of 23 patients with sta
ge I disease and in all 16 patients with dysgerminoma. Only 7 (11%) of
64 patients with mature benign cystic teratoma had elevated levels of
M-CSF. These results suggest that M-CSF is highly sensitive and speci
fic for malignant germ cell tumors of the ovary, especially for dysger
minoma. (C) 1998 Academic Press.